|
1
|
Münger K, Baldwin A, Edwards KM, et al:
Mechanisms of human papillomavirus-induced oncogenesis. J Virol.
78:11451–11460. 2004.
|
|
2
|
Karin M and Greten FR: NF-kappaB: linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baldwin AS Jr: The NF-kappa B and I kappa
B proteins: new discoveries and insights. Annu Rev Immunol.
14:649–683. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang C, Ling H, Zhang M, et al: Oxidative
stress mediates chemical hypoxia-induced injury and inflammation by
activating NF-κb-COX-2 pathway in HaCaT cells. Mol Cells.
31:531–538. 2011.PubMed/NCBI
|
|
5
|
Yang C, Yang Z, Zhang M, et al: Hydrogen
sulfide protects against chemical hypoxia-induced cytotoxicity and
inflammation in HaCaT cells through inhibition of ROS/NF-κB/COX-2
pathway. PLoS One. 6:e219712011.PubMed/NCBI
|
|
6
|
Guo RM, Xu WM, Lin JC, et al: Activation
of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced
inflammation and cytotoxicity in H9c2 cardiac cells. Mol Med Rep.
8:603–608. 2013.
|
|
7
|
Lu H, Ouyang W and Huang C: Inflammation,
a key event in cancer development. Mol Cancer Res. 4:221–233. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pollard JW: Tumour-educated macrophages
promote tumour progression and metastasis. Nat Rev Cancer. 4:71–78.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim SH, Oh JM, No JH, Bang YJ, Juhnn YS
and Song YS: Involvement of NF-kappaB and AP-1 in COX-2
upregulation by human papillomavirus 16 E5 oncoprotein.
Carcinogenesis. 30:753–757. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li J, Jia H, Xie L, et al: Association of
constitutive nuclear factor-kappaB activation with aggressive
aspects and poor prognosis in cervical cancer. Int J Gynecol
Cancer. 19:1421–1426. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu Z, Peng X, Li J, Zhang Y and Hu L:
Constitutive activation of nuclear factor κB contributes to cystic
fibrosis transmembrane conductance regulator expression and
promotes human cervical cancer progression and poor prognosis. Int
J Gynecol Cancer. 23:906–915. 2013.
|
|
12
|
Agarwal B, Rao CV, Bhendwal S, Ramey WR,
Shirin H, Reddy BS and Holt PR: Lovastatin augments
sulindac-induced apoptosis in colon cancer cells and potentiates
chemopreventive effects of sulindac. Gastroenterology. 117:838–847.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vane JR, Bakhle YS and Botting RM:
Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 38:97–120.
1998. View Article : Google Scholar
|
|
14
|
Bae SH, Jung ES, Park YM, Kim BS, Kim BK,
Kim DG and Ryu WS: Expression of cyclooxygenase-2 (COX-2) in
hepato-cellular carcinoma and growth inhibition of hepatoma cell
lines by a COX-2 inhibitor, NS-398. Clin Cancer Res. 7:1410–1418.
2001.PubMed/NCBI
|
|
15
|
Dubois RN: Review article: cyclooxygenase
- a target for colon cancer prevention. Aliment Pharmacol Ther.
14(Suppl 1): 64–67. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hsu AL, Ching TT, Wang DS, Song X,
Rangnekar VM and Chen CS: The cyclooxygenase-2 inhibitor celecoxib
induces apoptosis by blocking Akt activation in human prostate
cancer cells independently of Bcl-2. J Biol Chem. 275:11397–11403.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Grossman EM, Longo WE, Panesar N, Mazuski
JE and Kaminski DL: The role of cyclooxygenase enzymes in the
growth of human gall bladder cancer cells. Carcinogenesis.
21:1403–1409. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Khuri FR, Wu H, Lee JJ, et al:
Cyclooxygenase-2 overexpression is a marker of poor prognosis in
stage I non-small cell lung cancer. Clin Cancer Res. 7:861–867.
2001.PubMed/NCBI
|
|
19
|
Higashi Y, Kanekura T and Kanzaki T:
Enhanced expression of cyclooxygenase (COX)-2 in human skin
epidermal cancer cells: evidence for growth suppression by
inhibiting COX-2 expression. Int J Cancer. 86:667–671. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kulkarni S, Rader JS, Zhang F, et al:
Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin
Cancer Res. 7:429–434. 2001.PubMed/NCBI
|
|
21
|
Ferrandina G, Lauriola L, Distefano MG, et
al: Increased cyclooxygenase-2 expression is associated with
chemotherapy resistance and poor survival in cervical cancer
patients. J Clin Oncol. 20:973–981. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ryu HS, Chang KH, Yang HW, Kim MS, Kwon HC
and Oh KS: High cyclooxygenase-2 expression in stage IB cervical
cancer with lymph node metastasis or parametrial invasion. Gynecol
Oncol. 76:320–325. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gaffney DK, Holden J, Davis M, Zempolich
K, Murphy KJ and Dodson M: Elevated cyclooxygenase-2 expression
correlates with diminished survival in carcinoma of the cervix
treated with radiotherapy. Int J Radiat Oncol Biol Phys.
49:1213–1217. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Weppelmann B and Mönkemeier D: The
influence of prostaglandin antagonists on radiation therapy of
carcinoma of the cervix. Gynecol Oncol. 17:196–199. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang AH, Tian XY, Yu JJ, Mi JQ, Liu H and
Wang RF: Celecoxib radiosensitizes the human cervical cancer HeLa
cell line via a mechanism dependent on reduced cyclo-oxygenase-2
and vascular endothelial growth factor C expression. J Int Med Res.
40:56–66. 2012. View Article : Google Scholar
|
|
26
|
Kang YJ, Wingerd BA, Arakawa T and Smith
WL: Cyclooxygenase-2 gene transcription in a macrophage model of
inflammation. J Immunol. 177:8111–8122. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu W, Reinmuth N, Stoeltzing O, et al:
Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human
colorectal cancer cells via multiple signaling pathways. Cancer
Res. 63:3632–3636. 2003.PubMed/NCBI
|
|
28
|
Thornberry NA, Bull HG, Calaycay JR, et
al: A novel heterodimeric cysteine protease is required for
interleukin-1 beta processing in monocytes. Nature. 356:768–774.
1992. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lamkanfi M, Kalai M, Saelens X, Declercq W
and Vandenabeele P: Caspase-1 activates nuclear factor of the
kappa-enhancer in B cells independently of its enzymatic activity.
J Biol Chem. 279:24785–24793. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sarkar A, Duncan M, Hart J, Hertlein E,
Guttridge DC and Wewers MD: ASC directs NF-kappaB activation by
regulating receptor interacting protein-2 (RIP2) caspase-1
interactions. J Immunol. 176:4979–4986. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang WH, Wang X, Narayanan M, Zhang Y,
Huo C, Reed JC and Friedlander RM: Fundamental role of the
Rip2/caspase-1 pathway in hypoxia and ischemia-induced neuronal
cell death. Proc Natl Acad Sci USA. 100:16012–16017. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Feng Q, Li P, Salamanca C, Huntsman D,
Leung PC and Auersperg N: Caspase-1alpha is down-regulated in human
ovarian cancer cells and the overexpression of caspase-1alpha
induces apoptosis. Cancer Res. 65:8591–8596. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Winter RN, Rhee JG and Kyprianou N:
Caspase-1 enhances the apoptotic response of prostate cancer cells
to ionizing radiation. Anticancer Res. 24:1377–1386.
2004.PubMed/NCBI
|
|
34
|
Schlosser S, Gansauge F, Ramadani M, Beger
HG and Gansauge S: Inhibition of caspase-1 induces cell death in
pancreatic carcinoma cells and potentially modulates expression
levels of bcl-2 family proteins. FEBS Lett. 491:104–108. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen J, Guo R, Yan H, et al: Naringin
inhibits ROS-activated MAPK pathway in high glucose-induced
injuries in H9c2 cardiac cells. Basic Clin Pharmacol Toxicol.
114:293–304. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mahmoud AM, Ashour MB, Abdel-Moneim A and
Ahmed OM: Hesperidin and naringin attenuate hyper-glycemia-mediated
oxidative stress and proinflammatory cytokine production in high
fat fed/streptozotocin-induced type 2 diabetic rats. J Diabetes
Complications. 26:483–490. 2012. View Article : Google Scholar
|
|
37
|
Nie YC, Wu H, Li PB, et al:
Anti-inflammatory effects of naringin in chronic pulmonary
neutrophilic inflammation in cigarette smoke-exposed rats. J Med
Food. 15:894–900. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Huang H and Wu K, You Q, Huang R, Li S and
Wu K: Naringin inhibits high glucose-induced cardiomyocyte
apoptosis by attenuating mitochondrial dysfunction and modulating
the activation of the p38 signaling pathway. Int J Mol Med.
32:396–402. 2013.
|
|
39
|
Chen J, Mo H, Guo R, You Q, Huang R and Wu
K: Inhibition of the leptin-induced activation of the p38 MAPK
pathway contributes to the protective effects of naringin against
high glucose-induced injury in H9c2 cardiac cells. Int J Mol Med.
33:605–612. 2014.PubMed/NCBI
|
|
40
|
Kaul TN, Middleton E Jr and Ogra PL:
Antiviral effect of flavonoids on human viruses. J Med Virol.
15:71–79. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
So FV, Guthrie N, Chambers AF, Moussa M
and Carroll KK: Inhibition of human breast cancer cell
proliferation and delay of mammary tumorigenesis by flavonoids and
citrus juices. Nutr Cancer. 26:167–181. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Le Marchand L, Murphy SP, Hankin JH,
Wilkens LR and Kolonel LN: Intake of flavonoids and lung cancer. J
Natl Cancer Inst. 92:154–160. 2000.PubMed/NCBI
|
|
43
|
Vanamala J, Leonardi T, Patil BS, et al:
Suppression of colon carcinogenesis by bioactive compounds in
grapefruit. Carcinogenesis. 27:1257–1265. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kim DI, Lee SJ, Lee SB, Park K, Kim WJ and
Moon SK: Requirement for Ras/Raf/ERK pathway in naringin-induced
G1-cell-cycle arrest via p21WAF1 expression. Carcinogenesis.
29:1701–1709. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Schindler R and Mentlein R: Flavonoids and
vitamin E reduce the release of the angiogenic peptide vascular
endothelial growth factor from human tumor cells. J Nutr.
136:1477–1482. 2006.PubMed/NCBI
|
|
46
|
Ramesh E and Alshatwi AA: Naringin induces
death receptor and mitochondria-mediated apoptosis in human
cervical cancer (SiHa) cells. Food Chem Toxicol. 51:97–105. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Choi JS and Ryter SW: Inflammasomes:
Molecular Regulation and Implications for Metabolic and Cognitive
Diseases. Mol Cells. May 19–2014.(Epub ahead of print).
|
|
48
|
Man SM, Tourlomousis P, Hopkins L, Monie
TP, Fitzgerald KA and Bryant CE: Salmonella infection
induces recruitment of Caspase-8 to the inflammasome to modulate
IL-1β production. J Immunol. 191:5239–5246. 2013. View Article : Google Scholar
|
|
49
|
Yusup G, Akutsu Y, Mutallip M, et al: A
COX-2 inhibitor enhances the antitumor effects of chemotherapy and
radiotherapy for esophageal squamous cell carcinoma. Int J Oncol.
44:1146–1152. 2014.PubMed/NCBI
|
|
50
|
Jarry A, Vallette G, Cassagnau E, et al:
Interleukin 1 and interleukin 1beta converting enzyme (caspase 1)
expression in the human colonic epithelial barrier. Caspase 1
downregulation in colon cancer. Gut. 45:246–251. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ueki T, Takeuchi T, Nishimatsu H, et al:
Silencing of the caspase-1 gene occurs in murine and human renal
cancer cells and causes solid tumor growth in vivo. Int J Cancer.
91:673–679. 2001. View Article : Google Scholar
|
|
52
|
Alnemri ES, Fernandes-Alnemri T and
Litwack G: Cloning and expression of four novel isoforms of human
interleukin-1 beta converting enzyme with different apoptotic
activities. J Biol Chem. 270:4312–4317. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chen YC, Shen SC, Chow JM, Ko CH and Tseng
SW: Flavone inhibition of tumor growth via apoptosis in
vitro and in vivo. Int J Oncol. 25:661–670.
2004.PubMed/NCBI
|
